Meta-analysis of the effects on safety of front-loading (FL), every-2-week (Q2W), and Q3W dosing of darbepoetin alfa (DA) in patients (pts) with chemotherapy-induced anemia (CIA).
John A. Glaspy
Consultant or Advisory Role - Amgen
Research Funding - Amgen
Dusan Kotasek
No relevant relationships to disclose
Jean-Luc Canon
Research Funding - GHDC
Dianne Tomita
Employment or Leadership Position - Amgen (B)
Stock Ownership - Amgen (B)
Helen Collins
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Lee Steven Schwartzberg
No relevant relationships to disclose